Ligand validation:8H8R

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.36
8H8R_LFA_P_310	19%	96%	0.218	0.832	0.19	0.16	-	-	3	0	90%	0.36
8H8R_LFA_C_314	18%	92%	0.225	0.872	0.3	0.25	-	-	3	0	65%	0.39
8H8R_LFA_N_609	17%	85%	0.291	0.928	0.35	0.4	-	-	2	0	70%	0.42
8H8R_LFA_B_306	14%	93%	0.286	0.862	0.34	0.17	-	-	3	0	85%	0.51
8H8R_LFA_N_601	14%	93%	0.274	0.849	0.28	0.21	-	-	1	0	85%	0.51
8H8R_LFA_P_314	13%	91%	0.258	0.859	0.31	0.25	-	-	3	0	65%	0.39
8H8R_LFA_A_607	11%	90%	0.314	0.886	0.36	0.25	-	-	3	0	70%	0.42
8H8R_LFA_P_313	11%	93%	0.279	0.837	0.27	0.22	-	-	0	0	75%	0.45
8H8R_LFA_T_103	8%	96%	0.273	0.831	0.23	0.13	-	-	0	0	55%	0.33
8H8R_LFA_O_302	7%	96%	0.256	0.788	0.23	0.15	-	-	4	0	55%	0.33
8H8R_LFA_A_608	7%	69%	0.292	0.793	0.64	0.54	-	-	9	0	70%	0.42
8H8R_LFA_C_313	7%	87%	0.285	0.775	0.27	0.41	-	-	1	0	75%	0.45
8H8R_LFA_N_610	6%	77%	0.294	0.788	0.55	0.38	-	-	2	0	70%	0.42
8H8R_LFA_C_311	4%	96%	0.339	0.787	0.23	0.12	-	-	0	0	70%	0.35
8H8R_LFA_P_301	4%	95%	0.413	0.843	0.23	0.16	-	-	4	0	75%	0.3
8H8R_LFA_P_312	4%	93%	0.38	0.836	0.2	0.3	-	-	2	0	55%	0.275
8H8R_LFA_T_102	3%	96%	0.355	0.769	0.23	0.13	-	-	1	0	70%	0.35
8H8R_LFA_C_307	3%	97%	0.421	0.86	0.14	0.19	-	-	5	0	55%	0.22
8H8R_LFA_C_310	3%	99%	0.357	0.793	0.13	0.1	-	-	2	0	55%	0.275
8H8R_LFA_C_312	3%	95%	0.401	0.799	0.23	0.17	-	-	5	0	55%	0.275
8H8R_LFA_C_325	2%	99%	0.447	0.776	0.14	0.1	-	-	5	0	75%	0.3
8H8R_LFA_P_311	1%	98%	0.362	0.631	0.16	0.09	-	-	5	0	55%	0.275
8H8R_LFA_P_309	1%	99%	0.548	0.83	0.17	0.07	-	-	0	0	30%	12
8H8R_LFA_P_308	1%	93%	0.435	0.645	0.22	0.26	-	-	2	0	55%	0.22
8H8R_LFA_C_308	0%	99%	0.548	0.708	0.19	0.05	-	-	0	0	30%	12
7COH_LFA_C_716	28%	97%	0.152	0.821	0.17	0.16	-	-	3	0	90%	0.36
8H8S_LFA_P_309	24%	94%	0.213	0.861	0.22	0.23	-	-	5	0	90%	0.36
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.